Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations

Authors: Tuula K Outinen, Satu M Mäkelä, Ilpo O Ala-Houhala, Heini SA Huhtala, Mikko Hurme, Antti S Paakkala, Ilkka H Pörsti, Jaana T Syrjänen, Jukka T Mustonen

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Nephropathia epidemica (NE) is a Scandinavian type of hemorrhagic fever with renal syndrome caused by Puumala hantavirus. The clinical course of the disease varies greatly in severity. The aim of the present study was to evaluate whether plasma C-reactive protein (CRP) and interleukin (IL)-6 levels associate with the severity of NE.

Methods

A prospectively collected cohort of 118 consecutive hospital-treated patients with acute serologically confirmed NE was examined. Plasma IL-6, CRP, and creatinine, as well as blood cell count and daily urinary protein excretion were measured on three consecutive days after admission. Plasma IL-6 and CRP levels higher than the median were considered high.

Results

We found that high IL-6 associated with most variables reflecting the severity of the disease. When compared to patients with low IL-6, patients with high IL-6 had higher maximum blood leukocyte count (11.9 vs 9.0 × 109/l, P = 0.001) and urinary protein excretion (2.51 vs 1.68 g/day, P = 0.017), as well as a lower minimum blood platelet count (55 vs 80 × 109/l, P < 0.001), hematocrit (0.34 vs 0.38, P = 0.001), and urinary output (1040 vs 2180 ml/day, P < 0.001). They also stayed longer in hospital than patients with low IL-6 (8 vs 6 days, P < 0.001). In contrast, high CRP did not associate with severe disease.

Conclusions

High plasma IL-6 concentrations associate with a clinically severe acute Puumala hantavirus infection, whereas high plasma CRP as such does not reflect the severity of the disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmaljohn CS, Dalrymple JM: Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology. 1983, 131: 482-491. 10.1016/0042-6822(83)90514-7.CrossRefPubMed Schmaljohn CS, Dalrymple JM: Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology. 1983, 131: 482-491. 10.1016/0042-6822(83)90514-7.CrossRefPubMed
2.
go back to reference Kanerva M, Mustonen J, Vaheri A: Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol. 1998, 8: 67-86. 10.1002/(SICI)1099-1654(199804/06)8:2<67::AID-RMV217>3.0.CO;2-U.CrossRefPubMed Kanerva M, Mustonen J, Vaheri A: Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol. 1998, 8: 67-86. 10.1002/(SICI)1099-1654(199804/06)8:2<67::AID-RMV217>3.0.CO;2-U.CrossRefPubMed
3.
go back to reference Brummer-Korvenkontio M, Vaheri A, Hovi T, von Bonsdorff CH, Vuorimies J, Manni T, Penttinen K, Oker-Blom N, Lähdevirta J: Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis. 1980, 141: 131-134.CrossRefPubMed Brummer-Korvenkontio M, Vaheri A, Hovi T, von Bonsdorff CH, Vuorimies J, Manni T, Penttinen K, Oker-Blom N, Lähdevirta J: Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis. 1980, 141: 131-134.CrossRefPubMed
4.
go back to reference Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis. 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6.CrossRefPubMed Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis. 2003, 3: 653-661. 10.1016/S1473-3099(03)00774-6.CrossRefPubMed
5.
go back to reference Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A: Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis. 1999, 31: 427-435. 10.1080/00365549950163941.CrossRefPubMed Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A: Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis. 1999, 31: 427-435. 10.1080/00365549950163941.CrossRefPubMed
6.
go back to reference Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A: Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996, 49: 217-221. 10.1038/ki.1996.29.CrossRefPubMed Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A: Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 1996, 49: 217-221. 10.1038/ki.1996.29.CrossRefPubMed
7.
go back to reference Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis. 2002, 186: 843-846. 10.1086/342413.CrossRefPubMed Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Partanen J, Vapalahti O, Vaheri A, Pasternack A: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis. 2002, 186: 843-846. 10.1086/342413.CrossRefPubMed
8.
go back to reference Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A: Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994, 26: 7-13. 10.3109/00365549409008583.CrossRefPubMed Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A: Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994, 26: 7-13. 10.3109/00365549409008583.CrossRefPubMed
9.
go back to reference Lähdevirta J: Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res. 1971, 3: 1-54.PubMed Lähdevirta J: Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res. 1971, 3: 1-54.PubMed
10.
go back to reference Linderholm M, Billstrom A, Settergren B, Tärnvik A: Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection. 1992, 20: 263-266. 10.1007/BF01710791.CrossRefPubMed Linderholm M, Billstrom A, Settergren B, Tärnvik A: Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection. 1992, 20: 263-266. 10.1007/BF01710791.CrossRefPubMed
11.
go back to reference Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A: Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol. 1996, 46: 369-378.PubMed Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A: Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol. 1996, 46: 369-378.PubMed
12.
go back to reference Paakkala A, Lempinen L, Paakkala T, Huhtala H, Mustonen J: Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med. 2004, 15: 284-290. 10.1016/j.ejim.2004.07.001.CrossRefPubMed Paakkala A, Lempinen L, Paakkala T, Huhtala H, Mustonen J: Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med. 2004, 15: 284-290. 10.1016/j.ejim.2004.07.001.CrossRefPubMed
13.
go back to reference Cosgriff TM: Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis. 1991, 13: 97-107.CrossRefPubMed Cosgriff TM: Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis. 1991, 13: 97-107.CrossRefPubMed
14.
go back to reference Temonen M, Vapalahti O, Holthöfer H, Brummer-Korvenkontio M, Vaheri A, Lankinen H: Susceptibility of human cells to Puumala virus infection. J Gen Virol. 1993, 74 (Pt 3): 515-518. 10.1099/0022-1317-74-3-515.CrossRefPubMed Temonen M, Vapalahti O, Holthöfer H, Brummer-Korvenkontio M, Vaheri A, Lankinen H: Susceptibility of human cells to Puumala virus infection. J Gen Virol. 1993, 74 (Pt 3): 515-518. 10.1099/0022-1317-74-3-515.CrossRefPubMed
15.
go back to reference Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 2004, 43: 809-816. 10.1053/j.ajkd.2003.12.044.CrossRefPubMed Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A, Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 2004, 43: 809-816. 10.1053/j.ajkd.2003.12.044.CrossRefPubMed
16.
go back to reference Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996, 78: 47-55. 10.1006/clin.1996.0007.CrossRefPubMed Temonen M, Mustonen J, Helin H, Pasternack A, Vaheri A, Holthöfer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol. 1996, 78: 47-55. 10.1006/clin.1996.0007.CrossRefPubMed
17.
go back to reference Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis. 1996, 173: 38-43.CrossRefPubMed Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis. 1996, 173: 38-43.CrossRefPubMed
18.
go back to reference Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA: High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999, 179: 295-302. 10.1086/314597.CrossRefPubMed Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA: High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis. 1999, 179: 295-302. 10.1086/314597.CrossRefPubMed
19.
go back to reference Klingström J, Plyusnin A, Vaheri A, Lundkvist Å: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol. 2002, 76: 444-449. 10.1128/JVI.76.1.444-449.2002.CrossRefPubMedPubMedCentral Klingström J, Plyusnin A, Vaheri A, Lundkvist Å: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol. 2002, 76: 444-449. 10.1128/JVI.76.1.444-449.2002.CrossRefPubMedPubMedCentral
20.
go back to reference Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G: Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. Embo J. 1989, 8: 3773-3779.PubMedPubMedCentral Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G: Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. Embo J. 1989, 8: 3773-3779.PubMedPubMedCentral
21.
go back to reference Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG: Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001, 64: 262-268. 10.1002/jmv.1045.CrossRefPubMed Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG: Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol. 2001, 64: 262-268. 10.1002/jmv.1045.CrossRefPubMed
22.
go back to reference Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998, 101: 643-649. 10.1172/JCI1355.CrossRefPubMedPubMedCentral Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE: Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998, 101: 643-649. 10.1172/JCI1355.CrossRefPubMedPubMedCentral
23.
go back to reference Vapalahti O, Lundkvist Å, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A: Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol. 1996, 34: 119-125.PubMedPubMedCentral Vapalahti O, Lundkvist Å, Kallio-Kokko H, Paukku K, Julkunen I, Lankinen H, Vaheri A: Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol. 1996, 34: 119-125.PubMedPubMedCentral
24.
go back to reference Takala A, Lähdevirta J, Jansson SE, Vapalahti O, Orpana A, Karonen SL, Repo H: Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis. 2000, 181: 1964-1970. 10.1086/315522.CrossRefPubMed Takala A, Lähdevirta J, Jansson SE, Vapalahti O, Orpana A, Karonen SL, Repo H: Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis. 2000, 181: 1964-1970. 10.1086/315522.CrossRefPubMed
25.
go back to reference Winter PM, Dung NM, Loan HT, Kneen R, Wills B, le Thu T, House D, White NJ, Farrar JJ, Hart CA, Solomon T: Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis. 2004, 190: 1618-1626. 10.1086/423328.CrossRefPubMed Winter PM, Dung NM, Loan HT, Kneen R, Wills B, le Thu T, House D, White NJ, Farrar JJ, Hart CA, Solomon T: Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis. 2004, 190: 1618-1626. 10.1086/423328.CrossRefPubMed
26.
go back to reference Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA: Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007, 195: 1532-1540. 10.1086/515575.CrossRefPubMed Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA: Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007, 195: 1532-1540. 10.1086/515575.CrossRefPubMed
27.
go back to reference Elliott MB, Welliver RC, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE: Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol. 2007, 79: 447-456. 10.1002/jmv.20830.CrossRefPubMed Elliott MB, Welliver RC, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE: Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol. 2007, 79: 447-456. 10.1002/jmv.20830.CrossRefPubMed
28.
go back to reference Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM: Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006, 74: 142-147.PubMed Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM: Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006, 74: 142-147.PubMed
29.
go back to reference Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB: Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine. 2004, 27: 173-179. 10.1016/j.cyto.2004.05.007.CrossRefPubMed Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB: Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine. 2004, 27: 173-179. 10.1016/j.cyto.2004.05.007.CrossRefPubMed
30.
go back to reference Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004, 65: 1357-1365. 10.1111/j.1523-1755.2004.00512.x.CrossRefPubMed Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int. 2004, 65: 1357-1365. 10.1111/j.1523-1755.2004.00512.x.CrossRefPubMed
31.
go back to reference Kadiroglu AK, Sit D, Atay AE, Kayabasi H, Altintas A, Yilmaz ME: The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. Ren Fail. 2007, 29: 503-508. 10.1080/08860220701274991.CrossRefPubMed Kadiroglu AK, Sit D, Atay AE, Kayabasi H, Altintas A, Yilmaz ME: The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. Ren Fail. 2007, 29: 503-508. 10.1080/08860220701274991.CrossRefPubMed
32.
go back to reference Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW: Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum. 2005, 52: 642-650. 10.1002/art.20846.CrossRefPubMed Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW: Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum. 2005, 52: 642-650. 10.1002/art.20846.CrossRefPubMed
33.
go back to reference Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS, Du Clos TW: C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. J Immunol. 2007, 178: 530-538.CrossRefPubMed Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS, Du Clos TW: C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors. J Immunol. 2007, 178: 530-538.CrossRefPubMed
34.
go back to reference Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, Du Clos TW: Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum. 2006, 54: 325-335. 10.1002/art.21556.CrossRefPubMed Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, Du Clos TW: Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum. 2006, 54: 325-335. 10.1002/art.21556.CrossRefPubMed
35.
go back to reference Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ: Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004, 13: 137-147. 10.1093/hmg/ddh021.CrossRefPubMed Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, Powell RJ, Isenberg DA, Walport MJ, Vyse TJ: Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet. 2004, 13: 137-147. 10.1093/hmg/ddh021.CrossRefPubMed
36.
go back to reference Penttinen K, Lähdevirta J, Kekomäki R, Ziola B, Salmi A, Hautanen A, Lindström P, Vaheri A, Brummer-Korvenkontio M, Wager O: Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis. 1981, 143: 15-21.CrossRefPubMed Penttinen K, Lähdevirta J, Kekomäki R, Ziola B, Salmi A, Hautanen A, Lindström P, Vaheri A, Brummer-Korvenkontio M, Wager O: Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J Infect Dis. 1981, 143: 15-21.CrossRefPubMed
37.
go back to reference Mitaka C: Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005, 351: 17-29. 10.1016/j.cccn.2004.08.018.CrossRefPubMed Mitaka C: Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005, 351: 17-29. 10.1016/j.cccn.2004.08.018.CrossRefPubMed
Metadata
Title
The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations
Authors
Tuula K Outinen
Satu M Mäkelä
Ilpo O Ala-Houhala
Heini SA Huhtala
Mikko Hurme
Antti S Paakkala
Ilkka H Pörsti
Jaana T Syrjänen
Jukka T Mustonen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-132

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine